Materialsammlung zur internen Radiodekontamination von Personen

34. Fachinformation Dimaval ® 100, Heyl Chem.-pharm. Fabrik GmbH & Co.
KG, September 2004
35. Fachinformation Ditripentat-Heyl ® (DTPA), Heyl Chem.-pharm. Fabrik
GmbH & Co. KG, Mai 2005
36. Fachinformation Extin ® N, Opfermann Arzneimittel GmbH, Juli 2003
37. Fachinformation F.X. Passage ® SL, Wörwag Pharma GmbH & Co. KG, Februar
2007
38. Fachinformation Kalium jodatum 0,1 g, Merck KgaA, März 2001
39. Fachinformation Metalcaptase ® 150/300, Heyl Chem.-parm. Fabrik GmbH &
Co. KG, Juli 2004
40. Fachinformation Micropaque ® H.D. oral, Guerbet GmbH, Juli 2005
41. Fachinformation Phosphalugel ® , Yamanouchi Pharma GmbH, Oktober 2004
42. Fachinformation Radiogardase ® , Heyl chem.-pharm. Fabrik GmbH & Co.
KG, Juli 2004
43. Fachinformation Thyrozol ® 5/10/20 Filmtabletten, Merck Pharma GmbH ,
Januar 2005
44. Fachinformation Zink-Trinatrium-Pentetat (Zn-DTPA), Heyl Chem.-pharm.
Fabrik GmbH & Co. KG, Juli 2004
45. Fisher D. R., Dunavant B. G., “Internal Decontamination of Radiocobalt”,
Health Phys. 35, pp. 279 – 285 (1978)
46. Fryxell G. E. et al., „Design and synthesis of self-assembled monolayers on
mesoporous supports (SAMMS): The importance of ligand posture in functional
nanomaterials”, J. Mater. Chem. 17, pp. 2863 - 2874 (2007)
47. Fukuda S., Iida H., Yan Y., Xie Y., Chen W., „Removal of strontium by the
chelating agent acetylamino propylidene diphosphonic acid in rats“, Health
Phys. 76(5), pp. 489-494; (1999)
48. Fukuda S. et al., „The Effects of Bicarbonate and its Combination with Chelating
Agents Used for the Removal of Depleted Uranium in Rats”, Hemoglobin
32 (1–2), pp.191–198 (2008)
49. Gerber G. B. and Thomas R.G. (eds.), “Guidebook for the Treatment of Accidental
Internal Radionuclide Contamination of Workers”, Radiat Prot Dosimetry
41 (1), pp. 3 – 49 (1992)
50. Gervelas, C. et al., “Direct lung delivery of a dry powder formulation of
DTPA with improved aerosolization properties: Effect on lung and systemic
decorporation of plutonium“, Journal of Controlled Release 118 pp.78–86
(2007)
51. Goossens L. H. J., Harrison J. D., Harper F. T., Kraan B. C. P., Cooke R. M.,
Hora S. C., “Probabilistic Accident Consequence Uncertainty Analysis: Internal
Dosimetry Uncertainty Assessment” NUREG/CR-6571, EUR16773
Luxembourg: Commission of the European Communities) Vols. 1 & 2
(1998)
52. Gorden A. E. V., Xu J., Raymond K. N. and Durbin P., „Rational Design of
Sequestering Agents for Plutonium and Other Actinides“, Chem. Rev. 103,
pp. 4207-4282 (2003)
53. Guilmette R. A., Bertelli L., Miller G., Little T. T., „Technical Basis for using
Nose Swab Bioassay Data for Early Internal Dose Assessment“, Radiation
Protection Dosimetry 2007 Aug 31, epub ahead of print
54. Guilmette R. A., Hakimi R., Durbin P. W., Xu J. and Raymond K.
N.,“Competitive Binding of Pu and Am with Bone Mineral and Novel Chelating
Agents”, Rad. Prot. Dosim.105 (1–4), pp. 527–534 (2003)
117